Table 2:
Investigation | Proportion of Patients |
---|---|
Brain imaging | |
MR imaging (± CT) | 92% (189/205) |
CT only | 8% (16/205) |
Conventional vascular imaging (cervical-cerebral) | |
CTA only | 18% (36/205) |
MRA only | 37% (75/205) |
CTA and MRA | 23% (47/205) |
CTA and DSA | 5% (11/205) |
MRA and DSA | 10% (20/205) |
CTA, MRA, and DSA | 8% (16/205) |
Cardiac investigations | |
Electrocardiography | 100% (205/205) |
Rhythm monitoring ≥24 hours | 29% (59/205) |
Transthoracic echocardiography | 68% (140/205) |
Transesophageal echocardiography | 6% (30/205) |
Laboratory investigations | |
Serology screen for vasculitis | 25% (51/205) |
Serology screen for hypercoagulability | 34% (69/205) |
CSF analysis | 14% (28/205) |
Brain biopsy | 2% (4/205) |